Benefit of Post-operative Surveillance for Recurrence after Curative Resection for Gastric Cancer

Background Although most clinicians perform surveillance after gastrectomy, there is no consensus on the optimal follow-up schedule. This study aimed to evaluate the benefit of postoperative surveillance for recurrence after curative resection for gastric cancer. Method We retrospectively studied 11...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal surgery 2010-06, Vol.14 (6), p.969-976
Main Authors: Kim, Jong-Han, Jang, You-Jin, Park, Sung-Soo, Park, Seong-Heum, Mok, Young-Jae
Format: Article
Language:English
Subjects:
Adult
Aged
Cancer
Female
Gastrectomy
Gastroenterology
Humans
Male
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Recurrence, Local - diagnosis
Original Article
Postoperative Period
Retrospective Studies
Risk Factors
Stomach Neoplasms - diagnosis
Stomach Neoplasms - surgery
Surgery
Survival Analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Although most clinicians perform surveillance after gastrectomy, there is no consensus on the optimal follow-up schedule. This study aimed to evaluate the benefit of postoperative surveillance for recurrence after curative resection for gastric cancer. Method We retrospectively studied 110 patients who had recurrences after undergoing curative gastrectomies between 2000 and 2004 at Korea University Hospital. We analyzed the clinico-pathologic factors and oncologic results according to the presence of recurrence symptoms. Results Fifty-five (50%) patients had symptomatic recurrences. There were significant differences in recurrence patterns; locoregional (29.1%) and peritoneal recurrences (27.3%) were dominant in asymptomatic group; peritoneal (47.3%) and hematogenous recurrences (25.5%) were dominant in symptomatic group. The median recurrence-free survival was not different for both groups ( p  = 0.054). However, median overall and post-recurrence survival was poor in the symptomatic group ( p  = 0.004, p  
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-010-1200-4